Patients who need continuous blood purification therapy
Conditions
Interventions
Research subjects receive continuous blood purification therapy using investigational drug WBCRRD or SPB-KT, according to random assignment. During the investigational treatment, the examinations and
Sponsors
Kinoshita Kaori
Eligibility
Inclusion criteria
Inclusion criteria: - Written informed consent from patients or legal representative if patients lack of ability to consent. - Over 20 years of age at the time of acquiring consent. - Indications: Fluid overload, Metabolic acidosis, Urine output, Electrolytes disturbance, Intoxication, Cytokine abnormal, Severe pancreatitis acute, Hepatitis fulminant or Postoperative hepatic failure. , etc.
Exclusion criteria
Exclusion criteria: - Patients who find it difficult to receive treatment under the conditions specified in the study protocol. - Patients who are pregnant at the time of consent for this study. - Patients participating in other clinical studies at the time of consent for this study. - Patients judged to be inadequate for this study by the investigators . , etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Both of serum potassium level and serum sodium level are corrected or maintained within the target control range. | — |
Contacts
Public ContactKaori Kinoshita
NIPRO CORPORATION
Outcome results
None listed